Epidemiology	O
and	O
cardiovascular	B:C0007222
comorbidities	O
in	O
patients	O
with	O
psoriasis	O
:	O
A	O
Korean	O
nationwide	I:C1556095
population	I:C1556095
-	I:C1556095
based	I:C1556095
cohort	O
study	O
.	O

Epidemiology	O
and	O
cardiovascular	O
comorbidities	O
in	O
patients	O
with	O
psoriasis	B:C0033860
:	O
A	O
Korean	O
nationwide	I:C1556095
population	I:C1556095
-	I:C1556095
based	I:C1556095
cohort	O
study	O
.	O

Epidemiology	O
and	O
cardiovascular	O
comorbidities	O
in	O
patients	O
with	O
psoriasis	O
:	O
A	O
Korean	B:C1556095
nationwide	I:C1556095
population	I:C1556095
-	I:C1556095
based	I:C1556095
cohort	O
study	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	B:C2603343
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	B:C0332128
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	B:C0263361
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	B:C0263361
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	B:C0003872
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	B:C0003872
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	B:C0078988
populations	O
.	O

There	O
is	O
a	O
lack	O
of	O
nationwide	O
studies	O
examining	O
the	O
epidemiology	O
and	O
comorbidities	O
of	O
psoriasis	O
vulgaris	I:C0263361
(	O
psoriasis	O
vulgaris	I:C0263361
)	O
and	O
psoriatic	O
arthritis	I:C0003872
(	O
psoriatic	O
arthritis	I:C0003872
)	O
in	O
Asian	O
populations	B:C1257890
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	B:C0033860
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	B:C0022771
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	B:C0007820
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	B:C0007222
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	B:C0007222
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	B:C0086930
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	B:C1257890
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
and	O
with	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
demographics	O
of	O
psoriasis	O
in	O
Korea	O
along	O
with	O
the	O
incidence	O
of	O
cerebro	O
-	O
cardiovascular	O
(	O
cardiovascular	O
)	O
comorbidities	O
and	O
to	O
compare	O
these	O
risks	O
between	O
populations	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
with	O
psoriasis	B:C0263361
vulgaris	I:C0263361
.	O

This	O
cohort	O
study	O
identified	O
15	O
484	O
patients	O
with	O
psoriasis	B:C0033860
among	O
855	O
003	O
subjects	O
in	O
the	O
Korean	O
National	O
Health	I:C0027452
Insurance	I:C0027452
Database	O
from	O
2002	O
through	O
2010	O
.	O

This	O
cohort	O
study	O
identified	O
15	O
484	O
patients	O
with	O
psoriasis	O
among	O
855	O
003	O
subjects	O
in	O
the	O
Korean	B:C1556095
National	O
Health	I:C0027452
Insurance	I:C0027452
Database	O
from	O
2002	O
through	O
2010	O
.	O

This	O
cohort	O
study	O
identified	O
15	O
484	O
patients	O
with	O
psoriasis	O
among	O
855	O
003	O
subjects	O
in	O
the	O
Korean	O
National	B:C0027452
Health	I:C0027452
Insurance	I:C0027452
Database	O
from	O
2002	O
through	O
2010	O
.	O

This	O
cohort	O
study	O
identified	O
15	O
484	O
patients	O
with	O
psoriasis	O
among	O
855	O
003	O
subjects	O
in	O
the	O
Korean	O
National	O
Health	I:C0027452
Insurance	I:C0027452
Database	B:C0242356
from	O
2002	O
through	O
2010	O
.	O

The	O
cases	O
were	O
further	B:C1517331
classified	O
into	O
psoriatic	O
arthritis	I:C0003872
and	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
cases	O
were	O
further	O
classified	B:C0008902
into	O
psoriatic	O
arthritis	I:C0003872
and	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
cases	O
were	O
further	O
classified	O
into	O
psoriatic	B:C0003872
arthritis	I:C0003872
and	O
psoriasis	O
vulgaris	I:C0263361
.	O

The	O
cases	O
were	O
further	O
classified	O
into	O
psoriatic	O
arthritis	I:C0003872
and	O
psoriasis	B:C0263361
vulgaris	I:C0263361
.	O

We	O
used	O
hazard	O
ratios	O
(	O
HR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
from	O
the	O
univariate	O
and	O
age	O
-	O
sex	O
adjusted	O
logistic	O
regression	O
model	O
to	O
assess	B:C0086930
the	I:C0086930
risk	I:C0086930
of	O
comorbidities	O
in	O
patients	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
psoriasis	O
vulgaris	I:C0263361
.	O

We	O
used	O
hazard	O
ratios	O
(	O
HR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
from	O
the	O
univariate	O
and	O
age	O
-	O
sex	O
adjusted	O
logistic	O
regression	O
model	O
to	O
assess	O
the	I:C0086930
risk	I:C0086930
of	O
comorbidities	O
in	O
patients	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
and	O
psoriasis	O
vulgaris	I:C0263361
.	O

We	O
used	O
hazard	O
ratios	O
(	O
HR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
CI	O
)	O
from	O
the	O
univariate	O
and	O
age	O
-	O
sex	O
adjusted	O
logistic	O
regression	O
model	O
to	O
assess	O
the	I:C0086930
risk	I:C0086930
of	O
comorbidities	O
in	O
patients	O
with	O
psoriatic	O
arthritis	I:C0003872
and	O
psoriasis	B:C0263361
vulgaris	I:C0263361
.	O

The	O
annual	O
prevalence	O
of	O
psoriasis	B:C0033860
increased	O
from	O
313.2	O
to	O
453.5/100	O
000	O
people	O
from	O
2002	O
through	O
2010	O
;	O
however	O
,	O
the	O
overall	O
incidence	O
rate	O
for	O
psoriasis	O
slightly	O
decreased	O
(	O
252.7-212.6/100	O
000	O
population	O
)	O
.	O

The	O
annual	O
prevalence	O
of	O
psoriasis	O
increased	O
from	O
313.2	O
to	O
453.5/100	O
000	O
people	B:C0027361
from	O
2002	O
through	O
2010	O
;	O
however	O
,	O
the	O
overall	O
incidence	O
rate	O
for	O
psoriasis	O
slightly	O
decreased	O
(	O
252.7-212.6/100	O
000	O
population	O
)	O
.	O

The	O
annual	O
prevalence	O
of	O
psoriasis	O
increased	O
from	O
313.2	O
to	O
453.5/100	O
000	O
people	O
from	O
2002	O
through	O
2010	O
;	O
however	O
,	O
the	O
overall	O
incidence	O
rate	O
for	O
psoriasis	B:C0033860
slightly	O
decreased	O
(	O
252.7-212.6/100	O
000	O
population	O
)	O
.	O

The	O
annual	O
prevalence	O
of	O
psoriasis	O
increased	O
from	O
313.2	O
to	O
453.5/100	O
000	O
people	O
from	O
2002	O
through	O
2010	O
;	O
however	O
,	O
the	O
overall	O
incidence	O
rate	O
for	O
psoriasis	O
slightly	O
decreased	O
(	O
252.7-212.6/100	O
000	O
population	B:C1257890
)	O
.	O

Of	O
psoriatic	B:C0033860
patients	O
,	O
10.8	O
%	O
had	O
psoriatic	O
arthritis	I:C0003872
,	O
and	O
after	O
adjusting	O
for	O
age	O
and	O
sex	O
,	O
psoriatic	O
arthritis	I:C0003872
patients	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
dyslipidemia	O
than	O
psoriasis	O
vulgaris	I:C0263361
patients	O
(	O
adjusted	O
HR	O
,	O
1.185	O
;	O
95	O
%	O
CI	O
,	O
1.049-1.338	O
)	O
.	O

Of	O
psoriatic	O
patients	O
,	O
10.8	O
%	O
had	O
psoriatic	B:C0003872
arthritis	I:C0003872
,	O
and	O
after	O
adjusting	O
for	O
age	O
and	O
sex	O
,	O
psoriatic	O
arthritis	I:C0003872
patients	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
dyslipidemia	O
than	O
psoriasis	O
vulgaris	I:C0263361
patients	O
(	O
adjusted	O
HR	O
,	O
1.185	O
;	O
95	O
%	O
CI	O
,	O
1.049-1.338	O
)	O
.	O

Of	O
psoriatic	O
patients	O
,	O
10.8	O
%	O
had	O
psoriatic	O
arthritis	I:C0003872
,	O
and	O
after	O
adjusting	O
for	O
age	O
and	O
sex	O
,	O
psoriatic	B:C0003872
arthritis	I:C0003872
patients	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
dyslipidemia	O
than	O
psoriasis	O
vulgaris	I:C0263361
patients	O
(	O
adjusted	O
HR	O
,	O
1.185	O
;	O
95	O
%	O
CI	O
,	O
1.049-1.338	O
)	O
.	O

Of	O
psoriatic	O
patients	O
,	O
10.8	O
%	O
had	O
psoriatic	O
arthritis	I:C0003872
,	O
and	O
after	O
adjusting	O
for	O
age	O
and	O
sex	O
,	O
psoriatic	O
arthritis	I:C0003872
patients	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
dyslipidemia	B:C0242339
than	O
psoriasis	O
vulgaris	I:C0263361
patients	O
(	O
adjusted	O
HR	O
,	O
1.185	O
;	O
95	O
%	O
CI	O
,	O
1.049-1.338	O
)	O
.	O

Of	O
psoriatic	O
patients	O
,	O
10.8	O
%	O
had	O
psoriatic	O
arthritis	I:C0003872
,	O
and	O
after	O
adjusting	O
for	O
age	O
and	O
sex	O
,	O
psoriatic	O
arthritis	I:C0003872
patients	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
dyslipidemia	O
than	O
psoriasis	B:C0263361
vulgaris	I:C0263361
patients	O
(	O
adjusted	O
HR	O
,	O
1.185	O
;	O
95	O
%	O
CI	O
,	O
1.049-1.338	O
)	O
.	O

When	O
stratified	O
by	O
age	O
group	O
,	O
subjects	O
aged	O
20	O
-	O
39	O
years	O
had	O
a	O
higher	O
risk	O
of	O
stroke	B:C0038454
and	O
many	O
cardiovascular	O
risk	O
factors	I:C0035648
.	O

When	O
stratified	O
by	O
age	O
group	O
,	O
subjects	O
aged	O
20	O
-	O
39	O
years	O
had	O
a	O
higher	O
risk	O
of	O
stroke	O
and	O
many	O
cardiovascular	B:C0007222
risk	O
factors	I:C0035648
.	O

When	O
stratified	O
by	O
age	O
group	O
,	O
subjects	O
aged	O
20	O
-	O
39	O
years	O
had	O
a	O
higher	O
risk	O
of	O
stroke	O
and	O
many	O
cardiovascular	O
risk	B:C0035648
factors	I:C0035648
.	O

In	O
conclusion	O
,	O
the	O
prevalence	O
of	O
psoriasis	B:C0033860
,	O
while	O
within	O
the	O
range	O
of	O
previous	O
reports	O
,	O
tended	O
to	O
increase	O
over	O
time	O
.	O

In	O
conclusion	O
,	O
the	O
prevalence	O
of	O
psoriasis	O
,	O
while	O
within	O
the	O
range	O
of	O
previous	O
reports	B:C0684224
,	O
tended	O
to	O
increase	O
over	O
time	O
.	O

Patients	O
with	O
psoriatic	B:C0003872
arthritis	I:C0003872
had	O
higher	O
burdens	O
of	O
specific	O
comorbid	O
diseases	I:C0012634
than	O
those	O
with	O
psoriasis	O
vulgaris	I:C0263361
,	O
especially	O
at	O
a	O
comparatively	O
early	O
age	O
.	O

Patients	O
with	O
psoriatic	O
arthritis	I:C0003872
had	O
higher	O
burdens	O
of	O
specific	O
comorbid	B:C0012634
diseases	I:C0012634
than	O
those	O
with	O
psoriasis	O
vulgaris	I:C0263361
,	O
especially	O
at	O
a	O
comparatively	O
early	O
age	O
.	O

Patients	O
with	O
psoriatic	O
arthritis	I:C0003872
had	O
higher	O
burdens	O
of	O
specific	O
comorbid	O
diseases	I:C0012634
than	O
those	O
with	O
psoriasis	B:C0263361
vulgaris	I:C0263361
,	O
especially	O
at	O
a	O
comparatively	O
early	O
age	O
.	O

